Clinical Trial Update: Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Injectafer to oral iron assessing response relative to baseline hepcidin levels in iron deficiency anemia due to inflammatory bowel dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Bypass
• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• INJECTAFER (ferric carboxymaltose injection)

Snippet

Sponsor: American Regent, Inc. | Conditions: Iron Deficiency Anemia Secondary to IBD or Gastric Bypass | Phase 4 | Status: COMPLETED | Results posted: 2020-09-17